PUBLISHER: The Business Research Company | PRODUCT CODE: 1942555
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942555
A cervical traction chair is a specialized medical device designed to gently stretch and decompress the neck (cervical spine) to relieve pressure on spinal discs and nerves. It is commonly utilized in physical therapy or chiropractic settings to treat conditions including neck pain, herniated discs, and cervical spondylosis, helping to improve posture and mobility.
The primary types of cervical traction chairs are manual cervical traction chairs and electric cervical traction chairs. A manual cervical traction chair is a device that provides traction therapy for the cervical spine through manual adjustment. These chairs are used for various applications, including neck pain relief, spinal alignment, posture correction, muscle relaxation, and rehabilitation. They are employed in different settings such as hospitals, clinics, home care environments, and rehabilitation centers.
Tariffs are impacting the cervical traction chair market by increasing costs of imported electric motors, control systems, metal frames, upholstery materials, and electronic components. Rehabilitation centers and hospitals in North America and Europe are most affected due to reliance on imported medical equipment, while Asia-Pacific faces cost pressures on device manufacturing and exports. These tariffs are raising equipment prices and extending replacement cycles. However, they are also encouraging local assembly, regional supplier partnerships, and development of cost-optimized traction chair designs.
The cervical traction chair market research report is one of a series of new reports from The Business Research Company that provides cervical traction chair market statistics, including cervical traction chair industry global market size, regional shares, competitors with a cervical traction chair market share, detailed cervical traction chair market segments, market trends and opportunities, and any further data you may need to thrive in the cervical traction chair industry. This cervical traction chair market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cervical traction chair market size has grown strongly in recent years. It will grow from $2.69 billion in 2025 to $2.87 billion in 2026 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to growing prevalence of cervical spine disorders, increasing use of non-surgical pain management therapies, expansion of physiotherapy clinics, rising awareness of posture-related conditions, availability of manual traction therapy solutions.
The cervical traction chair market size is expected to see strong growth in the next few years. It will grow to $3.7 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to increasing demand for advanced rehabilitation equipment, rising adoption of home healthcare devices, expansion of outpatient rehabilitation services, growing aging population with spinal conditions, continuous product innovation in physical therapy equipment. Major trends in the forecast period include increasing adoption of electric and programmable traction chairs, rising demand for ergonomic and adjustable designs, growing use in rehabilitation and physical therapy centers, expansion of home-based cervical therapy devices, enhanced focus on patient comfort and safety.
The rising incidence of back pain is expected to drive the growth of the cervical traction chair market. Back pain refers to discomfort or pain in the back, typically affecting the lower, middle, or upper regions of the spine. The high occurrence of back pain is often associated with poor posture or prolonged sitting, which puts strain on the muscles and spine, leading to discomfort or injury. A cervical traction chair helps alleviate back pain by gently stretching the spine, reducing pressure on the spinal discs and nerves, and promoting proper alignment and muscle relaxation. For example, a report from the Office for Health Improvement and Disparities, a UK-based government department, published in January 2024, indicated that in 2023, 18.4% of individuals aged 16 and over self-reported having a long-term musculoskeletal (MSK) condition, up from 17.6% in 2022. Consequently, the growing incidence of back pain is driving the expansion of the cervical traction chair market.
The increasing healthcare expenditure is expected to drive the growth of the cervical traction chair market. Healthcare expenditure refers to the financial resources allocated for the provision and consumption of healthcare services. As the population ages, healthcare spending tends to rise, as older individuals generally require more medical care and long-term treatments. Cervical traction chairs contribute to reducing healthcare costs by offering a cost-effective, non-invasive treatment for neck pain, thus reducing the need for expensive surgeries, medications, and prolonged rehabilitation. For example, in November 2024, the Health Foundation, a UK-based independent charity, reported that the Department of Health and Social Care (DHSC) plans to increase its total spending from $235.625 billion (£188.5 billion) in fiscal years 2023/24 to 2025/26 to $269.15 billion (£215.6 billion) in nominal terms, resulting in a real-terms growth rate of 3.2% annually. As a result, the rise in healthcare expenditure is contributing to the growth of the cervical traction chair market.
The growing prevalence of chronic diseases is expected to drive the growth of the cervical traction chair market. Chronic diseases are long-lasting conditions that can be managed but not cured. The increasing prevalence of chronic diseases is largely due to the aging population, as older individuals are more vulnerable to conditions including heart disease, which require long-term management. Cervical traction is particularly beneficial for chronic conditions by gently stretching the neck to relieve pressure on the spine and nerves, alleviating pain, improving mobility, and promoting long-term healing without the need for invasive treatments. For example, in June 2024, the National Health Service (NHS) England reported that in 2023, 3,615,330 individuals registered with a general practitioner were diagnosed with non-diabetic hyperglycemia (pre-diabetes), reflecting an 18% increase from 3,065,825 cases in 2022. As a result, the increasing prevalence of chronic diseases is contributing to the growth of the cervical traction chair market.
Major companies operating in the cervical traction chair market are Guangzhou Lety Medical Limited, India Medico Instruments, Wanrooemed, Henan Eminent Medical Devices Co. Ltd., Zhangjiagang Yongxin Medical Equipment Co. Ltd., Youjian (Hebei) Medical Equipment Co. Ltd., Guangzhou MeCan Medical Limited, Chinesport S.p.A., Chattanooga Group (DJO Global), Enraf-Nonius B.V., Zynex Medical Inc., Dynatronics Corporation, OG Wellness Technologies Co. Ltd., Cybertech Medical, Bird & Cronin LLC, Whitehall Manufacturing, Pivotal Health Solutions, Fisiotech S.r.l., HMS Medical Systems, V2U Healthcare
North America was the largest region in the cervical traction chair market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cervical traction chair market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cervical traction chair market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The cervical traction chair market consists of sales of hydraulic cervical traction chairs, pneumatic cervical traction chairs, multifunctional rehabilitation chairs, portable and home-use chairs, and chiropractic cervical traction chairs. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cervical Traction Chair Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses cervical traction chair market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cervical traction chair ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cervical traction chair market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.